Ohio Team Identifies SNP Tied to Increased MS Risk, Progression | GenomeWeb

Researchers from Ohio have identified a genetic mutation that may double an individual’s risk of developing multiple sclerosis and hasten its progression. If verified, the findings might present drug makers with a viable target, and help physicians better determine therapeutic strategies for their MS patients.

Investigators from the Ohio State University College of Medicine and Public Health focused on two versions of the CD24, which expresses a protein found on immune cells and influences immune responses.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.